These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28373036)
21. Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia. Tadele G; Jaiteh FK; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L Antimicrob Agents Chemother; 2022 Sep; 66(9):e0000222. PubMed ID: 35993723 [TBL] [Abstract][Full Text] [Related]
22. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial. Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine]. Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia. Mekonnen SK; Medhin G; Berhe N; Clouse RM; Aseffa A Malar J; 2015 Aug; 14():317. PubMed ID: 26271736 [TBL] [Abstract][Full Text] [Related]
25. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy. Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin. Ogouyèmi-Hounto A; Azandossessi C; Lawani S; Damien G; de Tove YS; Remoue F; Kinde Gazard D Malar J; 2016 Jan; 15():37. PubMed ID: 26801767 [TBL] [Abstract][Full Text] [Related]
30. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019. Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679 [TBL] [Abstract][Full Text] [Related]
32. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children. Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF Malar J; 2015 Jan; 14():27. PubMed ID: 25626448 [TBL] [Abstract][Full Text] [Related]
33. Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study. Ebstie YA; Zeynudin A; Belachew T; Desalegn Z; Suleman S Malar J; 2015 Jun; 14():236. PubMed ID: 26045199 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis. Ayalew MB Infect Dis Poverty; 2017 Nov; 6(1):157. PubMed ID: 29137664 [TBL] [Abstract][Full Text] [Related]
35. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial. Ursing J; Rombo L; Rodrigues A; Kofoed PE PLoS One; 2016; 11(9):e0161495. PubMed ID: 27649561 [TBL] [Abstract][Full Text] [Related]
36. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D Malar J; 2015 Dec; 14():504. PubMed ID: 26670642 [TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Carlsson AM; Ngasala BE; Dahlström S; Membi C; Veiga IM; Rombo L; Abdulla S; Premji Z; Gil JP; Björkman A; Mårtensson A Malar J; 2011 Dec; 10():380. PubMed ID: 22185672 [TBL] [Abstract][Full Text] [Related]
39. Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Chandra R; Ansah P; Sagara I; Sie A; Tiono AB; Djimde AA; Zhao Q; Robbins J; Penali LK; Ogutu B Malar J; 2015 Mar; 14():108. PubMed ID: 25881046 [TBL] [Abstract][Full Text] [Related]
40. Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia. Gubae K; Mohammed H; Sime H; Hailgiorgis H; Mare AK; Gidey B; Haile M; Assefa G; Bekele W; Tasew G; Abay SM; Assefa A Malar J; 2023 Jan; 22(1):9. PubMed ID: 36611179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]